STAT+: Sanofi, Regeneron expand partnership after Dupixent success

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: Sanofi, Regeneron expand partnership after Dupixent successWorldPing
Image via STAT.

What happened

Sanofi and Regeneron have re-upped their collaboration pact, aiming to build on the blockbuster success of the drug Dupixent.

Key facts

  • Reported by STAT and published Thu, 01 Oct 2026 06:16:27 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage